NASDAQ:BCORBlucora Stock Price, Forecast & News

Blucora's stock was trading at $13.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BCOR shares have decreased by 9.2% and is now trading at $11.84.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Blucora in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Blucora.

Blucora is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Blucora.

Blucora Inc (NASDAQ:BCOR) announced its quarterly earnings data on Wednesday, August, 5th. The information services provider reported $0.09 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.54 by $0.45. The information services provider earned $161.10 million during the quarter, compared to analyst estimates of $186.55 million. Blucora had a negative net margin of 43.01% and a positive return on equity of 4.84%. Blucora's revenue for the quarter was down 16.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.83 EPS.
View Blucora's earnings history.

Blucora issued an update on its FY20 earnings guidance on Wednesday, August, 5th. The company provided earnings per share (EPS) guidance of $0.83 to $0.98 for the period, compared to the Thomson Reuters consensus estimate of $1.11. The company issued revenue guidance of $733 million to $747 million, compared to the consensus revenue estimate of $743.36 million.

4 analysts have issued 1-year price objectives for Blucora's shares. Their forecasts range from $15.00 to $30.00. On average, they expect Blucora's share price to reach $22.75 in the next twelve months. This suggests a possible upside of 92.1% from the stock's current price.
View analysts' price targets for Blucora.

News coverage about BCOR stock has trended negative on Saturday, according to InfoTrie. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Blucora earned a news impact score of -2.7 on InfoTrie's scale. They also gave media coverage about the information services provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days.
View the latest news about Blucora.

Blucora saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 995,700 shares, a decrease of 21.0% from the June 15th total of 1,260,000 shares. Based on an average trading volume of 466,600 shares, the days-to-cover ratio is presently 2.1 days. Approximately 2.2% of the shares of the stock are sold short.
View Blucora's Short Interest.

Some companies that are related to Blucora include Facebook (FB), Equinix (EQIX), SEA (SE), eBay (EBAY), CoStar Group (CSGP), Twitter (TWTR), Verisign (VRSN), Akamai Technologies (AKAM), ANGI Homeservices (ANGI), Envestnet (ENV), Stamps.com (STMP), LogMeIn (LOGM), LivePerson (LPSN), J2 Global (JCOM) and Cimpress (CMPR).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Blucora investors own include BlackRock (BLK), CA (CA), Chipotle Mexican Grill (CMG), Endologix (ELGX), Tesla (TSLA), Honda Motor (HMC), Wells Fargo & Co (WFC), Accenture (ACN), Aegean Marine Petroleum Network (ANW) and Alibaba Group (BABA).

Blucora trades on the NASDAQ under the ticker symbol "BCOR."

Blucora's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.32%), Federated Hermes Inc. (2.32%), FMR LLC (1.15%), Bank of New York Mellon Corp (1.12%), Glenmede Trust Co. NA (1.04%) and Empirical Financial Services LLC d.b.a. Empirical Wealth Management (1.02%). Company insiders that own Blucora stock include Ann J Bruder, Christopher William Walters, H Mcintyre Gardner, John David Palmer, John S Clendening, Lance G Dunn, Marc Mehlman, Mark A Ernst, Mary Slagle Zappone, Mathieu Frederic Stevenson, Michael P Hogan, Robert D Oros, Todd C Mackay and William L Atwell.
View institutional ownership trends for Blucora.

BCOR stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Bank of New York Mellon Corp, State of Wisconsin Investment Board, Glenmede Trust Co. NA, Hancock Whitney Corp, Goldman Sachs Group Inc., State of Tennessee Treasury Department, and Prudential Financial Inc..
View insider buying and selling activity for Blucora.

BCOR stock was bought by a variety of institutional investors in the last quarter, including Federated Hermes Inc., Empirical Financial Services LLC d.b.a. Empirical Wealth Management, Tudor Investment Corp Et Al, Globeflex Capital L P, First Trust Advisors LP, SG Americas Securities LLC, Swiss National Bank, and FMR LLC. Company insiders that have bought Blucora stock in the last two years include Christopher William Walters, Marc Mehlman, Mark A Ernst, and Michael P Hogan.
View insider buying and selling activity for Blucora.

Shares of BCOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BCOR stock can currently be purchased for approximately $11.84.

Blucora has a market capitalization of $568.77 million and generates $717.95 million in revenue each year. The information services provider earns $48.15 million in net income (profit) each year or $1.85 on an earnings per share basis. Blucora employs 529 workers across the globe.

The official website for Blucora is www.blucora.com.

Blucora's mailing address is 3200 Olympus Blvd Suite 100, Dallas TX, 75019. The information services provider can be reached via phone at 972-870-6400 or via email at [email protected]